$ Value
$513K
Shares
3,903
Price
$131
Filed
Aug 15
Insider
Name
van der Vaart Sandra D
Title
EVP, Chief Legal Officer
CIK
0001537208
Roles
Transaction Details
Transaction Date
2025-08-13
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,177
Footnotes
Amount includes 30.1294 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan. | Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. | Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea. | The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.
Filing Info
van der Vaart Sandra D's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-26 | LH | A | $0 |
| 2026-03-26 | LH | F | $731K |
| 2026-02-27 | LH | ▼ | $156K |
| 2026-02-11 | LH | M | — |
| 2026-02-11 | LH | F | $29K |
| 2026-02-11 | LH | M | $0 |
| 2026-02-09 | LH | F | $25K |
| 2026-02-07 | LH | M | — |
| 2026-02-07 | LH | M | $0 |
| 2026-02-06 | LH | M | — |
Other Insiders at LH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
GRAHAM ANITA Z
EVP, CHRO
|
— | — | 2026-03-26 |
| ANDERSON KERRII B | — | — | 2026-02-11 |
| NEUPERT PETER M | — | — | 2026-02-11 |
|
Schechter Adam H
President & CEO
|
— | $3.9M | 2026-03-26 |
|
Wilkinson Peter J
SVP, Chief Accounting Officer
|
— | $621K | 2026-03-27 |
| Kong Garheng | — | — | 2026-02-11 |
|
van der Vaart Sandra D
EVP, Corporate Affairs
|
— | $156K | 2026-03-26 |
| Parham Richelle P | — | — | 2026-02-11 |
| Rothman Paul | — | — | 2026-02-11 |
| Davis Jeffrey A. | — | — | 2026-02-11 |
|
Caveney Brian J
EVP, Pres of ED, CMO & CSO
|
— | $429K | 2026-03-26 |
| Wengel Kathryn E | — | — | 2026-02-11 |
|
Schroeder Mark S
EVP, Pres Diagnostics & COO
|
— | — | 2026-03-26 |
|
Summy Amy B.
EVP, Chief Marketing Officer
|
— | — | 2026-03-26 |
|
Wang Julia Aijun
Chief Financial Officer, EVP
|
— | — | 2026-02-11 |
| Kliphouse Kirsten Marie | — | — | 2026-02-11 |
|
Bailey Megan D.
EVP, Pres, Central Labs & Intl
|
— | — | 2026-03-26 |
|
Oyegunwa Akinbolade
EVP, CIO & CTO
|
— | — | 2026-03-26 |
| Bulto Carulla Victor | — | — | 2026-02-10 |
|
Kyle Kathryn W
EVP, Chief Legal Officer
|
— | — | 2026-03-26 |
|
Meltzer Jonathan C
EVP, Operations
|
— | $299K | 2026-03-27 |
|
Vaughn Bryan T
EVP, Diagnostics
|
— | — | 2026-03-26 |
| Sampson John H | — | — | 2026-02-10 |